Abstract
Aims Antazoline is a first-generation antihistamine with antiarrhythmic properties. This study examines potential electrophysiological effects of antazoline in short-QT-syndrome (SQTS) and long-QT-syndrome (LQTS). Methods and results Sixty-five rabbit hearts were Langendorff-perfused. Action potential duration at 90% of repolarization (APD90), QT-interval, spatial dispersion (DISP), and effective refractory period (ERP) were measured. The IK, ATP-opener pinacidil (1 μM, n = 14) reduced APD90 (-14 ms, P<0.01), QT-interval (-14 ms, P<0.01), and ERP (-11 ms, P<0.01), thus simulating acquired SQTS. Additional infusion of 20 μM antazoline prolonged repolarization. Under baseline conditions, ventricular fibrillation (VF) was inducible in 5 of 14 hearts (10 episodes) and in 5 of 14 pinacidil-treated hearts (21 episodes, P = ns). Antazoline significantly reduced induction of VF (0 episodes, P<0.05 each). Further 17 hearts were perfused with 100 μM sotalol and 17 hearts with 300 μM erythromycin to induce acquired LQTS2. In both groups, prolongation of APD90, QT-interval, and ERP was observed. Spatial dispersion was increased (sotalol: +26 ms, P< 0.01; erythromycin: +31 ms, P<0.01). Additional infusion of antazoline reduced DISP (sotalol: -22 ms, P<0.01; erythromycin: -26 ms, P < 0.01). Torsade de pointes (TdP) occurred in 6 of 17 sotalol-treated (22 episodes, P<0.05 each) and in 8 of 17 erythromycin-treated hearts (96 episodes P<0.05 each). Additional infusion of antazoline completely suppressed TdP in both groups (P<0.05 each). Acquired LQTS3 was induced by veratridine (0.5 μM, n = 17) and similar results were obtained (APD90: +24 ms, P<0.01, QT-interval: +58 ms, P<0.01, DISP: +38 ms, P<0.01). Torsade de pointes occurred in 10 of 17 hearts (41 episodes, P<0.05 each). Antazoline significantly reduced TdP (2 of 17 hearts, 4 episodes, P<0.05 each). Conclusion Antazoline significantly reduced induction of VF in an experimental model of acquired SQTS. In three experimental models of acquired LQTS, antazoline effectively suppressed TdP.
Author supplied keywords
Cite
CITATION STYLE
Ellermann, C., Sterneberg, M., Kochhäuser, S., Dechering, D. G., Fehr, M., Eckardt, L., & Frommeyer, G. (2018). Antiarrhythmic effect of antazoline in experimental models of acquired short- and long-QT-syndromes. Europace, 20(10), 1699–1706. https://doi.org/10.1093/europace/eux383
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.